An Open Label Extension Study of the Safety and Clinical Utility of IPX066 in Subjects With Parkinson's Disease
Clinical trial NCT01096186 · COMPLETED
Trial details
- NCT number
- NCT01096186
- Sponsor
- Impax Laboratories, LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-03-01
- Primary completion
- 2011-10-01
- Enrollment
- 617
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.